Overview

  • Product name

    Anti-CD59 antibody [EPR6425(2)]
    See all CD59 primary antibodies
  • Description

    Rabbit monoclonal [EPR6425(2)] to CD59
  • Host species

    Rabbit
  • Tested applications

    Suitable for: WB, IHC-Pmore details
    Unsuitable for: Flow Cyt,ICC or IP
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to a region within the extracellular domain of Human CD59 (UniProt P13987).

  • Positive control

    • HUVEC and BxPC3 cell lysates; Human placenta and tonsil tissues
  • General notes

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.

     

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.

Properties

Applications

Our Abpromise guarantee covers the use of ab133707 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 14 kDa.
IHC-P 1/100 - 1/250. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
  • Application notes
    Is unsuitable for Flow Cyt,ICC or IP.
  • Target

    • Function

      Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase.
      The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.
    • Involvement in disease

      Defects in CD59 are the cause of CD59 deficiency (CD59D) [MIM:612300].
    • Sequence similarities

      Contains 1 UPAR/Ly6 domain.
    • Post-translational
      modifications

      N- and O-glycosylated. The N-glycosylation mainly consists of a family of biantennary complex-type structures with and without lactosamine extensions and outer arm fucose residues. Also significant amounts of triantennary complexes (22%). Variable sialylation also present in the Asn-43 oligosaccharide. The predominant O-glycans are mono-sialylated forms of the disaccharide, Gal-beta-1,3GalNAc, and their sites of attachment are probably on Thr-76 and Thr-77. The GPI-anchor of soluble urinary CD59 has no inositol-associated phospholipid, but is composed of seven different GPI-anchor variants of one or more monosaccharide units. Major variants contain sialic acid, mannose and glucosamine Sialic acid linked to an N-acetylhexosamine-galactose arm is present in two variants.
      Glycated. Glycation is found in diabetic subjects, but only at minimal levels in nondiabetic subjects. Glycated CD59 lacks MAC-inhibitory function and confers to vascular complications of diabetes.
    • Cellular localization

      Cell membrane. Secreted. Soluble form found in a number of tissues.
    • Information by UniProt
    • Database links

    • Alternative names

      • 16.3A5 antibody
      • 1F5 antibody
      • 1F5 antigen antibody
      • 20 kDa homologous restriction factor antibody
      • CD 59 antibody
      • CD_antigen=CD59 antibody
      • CD59 antibody
      • CD59 antigen antibody
      • CD59 antigen complement regulatory protein antibody
      • CD59 antigen p18 20 antibody
      • CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344) antibody
      • CD59 glycoprotein antibody
      • CD59 molecule antibody
      • CD59 molecule complement regulatory protein antibody
      • CD59_HUMAN antibody
      • Cd59a antibody
      • Complement regulatory protein antibody
      • EJ16 antibody
      • EJ30 antibody
      • EL32 antibody
      • FLJ38134 antibody
      • FLJ92039 antibody
      • G344 antibody
      • HRF 20 antibody
      • HRF-20 antibody
      • HRF20 antibody
      • Human leukocyte antigen MIC11 antibody
      • Ly 6 like protein antibody
      • Lymphocytic antigen CD59/MEM43 antibody
      • MAC inhibitory protein antibody
      • MAC IP antibody
      • MAC-inhibitory protein antibody
      • MAC-IP antibody
      • MACIF antibody
      • MACIP antibody
      • MEM43 antibody
      • MEM43 antigen antibody
      • Membrane attack complex (MAC) inhibition factor antibody
      • Membrane attack complex inhibition factor antibody
      • Membrane inhibitor of reactive lysis antibody
      • MGC2354 antibody
      • MIC11 antibody
      • MIN1 antibody
      • MIN2 antibody
      • MIN3 antibody
      • MIRL antibody
      • MSK21 antibody
      • p18 20 antibody
      • Protectin antibody
      • Surface antigen recognized by monoclonal antibody 16.3A5 antibody
      • T cell activating protein antibody
      see all

    Images

    • Lane 1: Wild-type HAP1 whole cell lysate (40 µg)
      Lane 2: CD59 knockout HAP1 whole cell lysate (40 µg)

      Lanes 1 - 2: Merged signal (red and green). Green - ab133707 observed at 14 kDa. Red - loading control, ab9484, observed at 37 kDa.

      ab133707 was shown to specifically react with CD59 in wild-type HAP1 cells as signal was lost in CD59 knockout cells. Wild-type and CD59 knockout samples were subjected to SDS-PAGE. Ab133707 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

    • All lanes : Anti-CD59 antibody [EPR6425(2)] (ab133707) at 1/1000 dilution

      Lane 1 : HUVEC cell lysate
      Lane 2 : BxPC 3 cell lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution

      Predicted band size: 14 kDa

    • Immunohistochemical analysis of CD59 in paraffin embedded Human placenta tissue labelled with ab133707 at a 1/100 dilution.

      Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

    • Immunohistochemical analysis of CD59 in paraffin embedded Human tonsil tissue labelled with ab133707 at a 1/100 dilution.

      Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

    References

    This product has been referenced in:

    • Clark AJ & Petty HR Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy. Sci Rep 6:27039 (2016). Read more (PubMed: 27247112) »
    • Clark AJ & Petty HR Protocol for Biomarker Ratio Imaging Microscopy with Specific Application to Ductal Carcinoma In situ of the Breast. Front Cell Dev Biol 4:120 (2016). Read more (PubMed: 27857940) »
    See all 2 Publications for this product

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab133707.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Sign up